DNA repair and cell cycle checkpoint defects as drivers and therapeutic targets in melanoma

Sandra Pavey1, Loredana Spoerri, Nikolas K Haass

  • 1The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Qld, Australia.

Insights

Ultraviolet radiation (UVR) causes DNA damage in melanoma. Defects in DNA repair and cell cycle checkpoints allow mutations to accumulate, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ultraviolet radiation (UVR) is a primary environmental risk factor for melanoma.
  • UVR induces DNA damage, which can lead to mutations if not repaired.
  • Melanomas exhibit a high mutation rate with UVR-induced damage signatures, suggesting repair defects.

Purpose of the Study:

  • Investigate the role of DNA repair and cell cycle checkpoints in melanoma development.
  • Identify potential therapeutic strategies targeting defective mechanisms in melanoma.

Main Methods:

  • Analysis of mutation signatures in melanoma DNA.
  • Examination of DNA repair gene mutations.
  • Assessment of cell cycle checkpoint control mechanisms in melanoma cells.

Main Results:

  • Melanomas show significant UVR-induced DNA damage signatures.
  • Evidence suggests defects in DNA repair and cell cycle checkpoint pathways.
  • Somatic mutations in known repair genes are rare, except in specific hereditary syndromes.
  • Checkpoint defects are identified in melanomas, correlating with increased mutation load.

Conclusions:

  • Defective DNA repair and cell cycle checkpoints are key factors in melanoma mutagenesis.
  • Targeting compensatory mechanisms in defective checkpoints presents a potential synthetic lethal therapeutic strategy for melanoma.

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...